The transition of the vaccine candidate into human trials is an important milestone, and exemplifies a successful transfer of technology with BE, that could lead to a safe, effective and affordable vaccine, said the company.
from India Infoline News Service https://ift.tt/2IJwzCw
No comments:
Post a Comment